Comparative evaluation of CT and MRI in the preoperative staging of colon cancer.
Cancer
Colon
Computed
Diffusion
Magnetic
Tomography
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
26 Jul 2024
26 Jul 2024
Historique:
received:
18
04
2024
accepted:
19
07
2024
medline:
27
7
2024
pubmed:
27
7
2024
entrez:
26
7
2024
Statut:
epublish
Résumé
The aim of this study is to compare the diagnostic performance of magnetic resonance imaging (MRI) against computed tomography (CT) in various aspects of local staging in colon cancer patients. This study was a prospective single arm diagnostic accuracy study. All consecutive adult patients with confirmed colon cancer that met the current criteria for surgical resection were considered as eligible. Diagnostic performance assessment included T (T1/T2 vs T3/T4 and < T3ab vs > T3cd) and N (N positive) staging, serosa and retroperitoneal surgical margin (RSM) involvement and extramural vascular invasion (EMVI). Imaging was based on a 3 Tesla MRI system and the evaluation of all sequences (T1, T2 and diffusion-weighted imaging-DWI series) by two independent readers. CT scan was performed in a 128 row multidetector (MD) CT scanner (slice thickness: 1 mm) with intravenous contrast. Pathology report was considered as the gold standard for local staging. Sensitivity (SE), specificity (SP), and area under the curve (AUC) were calculated for both observers. MRI displayed a higher diagnostic performance over CT in terms of T1/T2 vs T3/T4 (SE: 100% vs 83.9%, SP: 96.6% vs 81%, AUC: 0.825 vs 0.983, p < 0.001), N positive (p < 0.001) and EMVI (p = 0.023) assessment. An excellent performance of MRI was noted in the T3ab vs T3cd (CT AUC
Identifiants
pubmed: 39060367
doi: 10.1038/s41598-024-68147-7
pii: 10.1038/s41598-024-68147-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
17145Informations de copyright
© 2024. The Author(s).
Références
Morgan, E. et al. Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN. Gut 72, 338–344 (2023).
doi: 10.1136/gutjnl-2022-327736
pubmed: 36604116
Siegel Mph, R. L. et al. Colorectal cancer statistics, 2023. CA Cancer J. Clin. 73, 233–254 (2023).
doi: 10.3322/caac.21772
Seow-En, I. & Chen, W. T. L. Complete mesocolic excision with central venous ligation/D3 lymphadenectomy for colon cancer—A comprehensive review of the evidence. Surg. Oncol. 42, 101755 (2022).
doi: 10.1016/j.suronc.2022.101755
pubmed: 35405620
Morton, D. et al. Preoperative chemotherapy for operable colon cancer: Mature results of an international randomized controlled trial. J. Clin. Oncol. 41, 1541–1552 (2023).
doi: 10.1200/JCO.22.00046
pubmed: 36657089
pmcid: 10022855
Hu, H. et al. Neoadjuvant chemotherapy with oxaliplatin and fluoropyrimidine versus upfront surgery for locally advanced colon cancer: The randomized, phase III OPTICAL trial. J. Clin. Oncol. https://doi.org/10.1200/JCO.23.01889/SUPPL_FILE/PROTOCOL_JCO.23.01889.PDF (2024).
doi: 10.1200/JCO.23.01889/SUPPL_FILE/PROTOCOL_JCO.23.01889.PDF
pubmed: 38574304
Vogel, J. D. et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the management of colon cancer. Dis. Colon Rectum 65, 148–177 (2022).
doi: 10.1097/DCR.0000000000002323
pubmed: 34775402
Luo, D. et al. Incidence, predictors and prognostic implications of positive circumferential resection margin in colon cancer: A retrospective study in a Chinese High-Volume Cancer Center. Front. Oncol. 12, 871570 (2022).
doi: 10.3389/fonc.2022.871570
pubmed: 36203420
pmcid: 9530821
Leijssen, L. G. J. et al. Impact of intramural and extramural vascular invasion on stage II–III colon cancer outcomes. J. Surg. Oncol. 119, 749–757 (2019).
doi: 10.1002/jso.25367
pubmed: 30644557
pmcid: 6629581
Basile, D. et al. Tumor budding is an independent prognostic factor in stage III colon cancer patients: A post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR). Ann. Oncol. 33, 628–637 (2022).
doi: 10.1016/j.annonc.2022.03.002
pubmed: 35306156
Swets, M. et al. Are pathological high-risk features in locally advanced rectal cancer a useful selection tool for adjuvant chemotherapy? Eur. J. Cancer 89, 1–8 (2018).
doi: 10.1016/j.ejca.2017.11.006
pubmed: 29223019
Kijima, S. et al. Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. World J. Gastroenterol. 20, 16964–16975 (2014).
doi: 10.3748/wjg.v20.i45.16964
pubmed: 25493009
pmcid: 4258565
Shkurti, J. et al. Diagnostic accuracy of CT for local staging of colon cancer: A nationwide study in the Netherlands. Eur. J. Cancer 193, 113314 (2023).
doi: 10.1016/j.ejca.2023.113314
pubmed: 37729742
Dighe, S. et al. Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: A multicentre experience. Colorectal Dis. 14, 438–444 (2012).
doi: 10.1111/j.1463-1318.2011.02638.x
pubmed: 21689323
Williams, C. J. M. et al. Incorporating neoadjuvant chemotherapy into locally advanced colon cancer treatment pathways: Real-life experience of implementing FOxTROT. Colorectal Dis. 25, 352–356 (2023).
doi: 10.1111/codi.16450
pubmed: 36511125
Nerad, E. et al. MRI for local staging of colon cancer: Can MRI become the optimal staging modality for patients with colon cancer? Dis. Colon Rectum 60, 385–392 (2017).
doi: 10.1097/DCR.0000000000000794
pubmed: 28267005
Liu, L. H., Lv, H., Wang, Z. C., Rao, S. X. & Zeng, M. S. Performance comparison between MRI and CT for local staging of sigmoid and descending colon cancer. Eur. J. Radiol. 121, 108741 (2019).
doi: 10.1016/j.ejrad.2019.108741
pubmed: 31743882
Dam, C. et al. Local staging of sigmoid colon cancer using MRI. Acta Radiol. Open 6, 205846011772095 (2017).
doi: 10.1177/2058460117720957
Rafaelsen, S. R. et al. CT and 3 Tesla MRI in the TN staging of colon cancer: A prospective, blind study. Curr. Oncol. 29, 1069–1079 (2022).
doi: 10.3390/curroncol29020091
pubmed: 35200590
pmcid: 8870524
Hunter, C. et al. Local staging and assessment of colon cancer with 1.5-T magnetic resonance imaging. Br. J. Radiol. 89, 20160257 (2016).
doi: 10.1259/bjr.20160257
pubmed: 27226219
pmcid: 5124895
Bossuyt, P. M. et al. STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies. BMJ 351, 826 (2015).
Shida, D. et al. Comparison of model fit and discriminatory ability of M category as defined by the 7th and 8th editions of the tumor-node-metastasis classification of colorectal cancer and the 9th edition of the Japanese classification. Cancer Med. 10, 6937 (2021).
doi: 10.1002/cam4.3972
pubmed: 34587374
pmcid: 8525077
Tejedor, P., Francis, N., Jayne, D., Hohenberger, W. & Khan, J. Consensus statements on complete mesocolic excision for right-sided colon cancer—Technical steps and training implications. Surg. Endosc. 36, 5595–5601 (2022).
doi: 10.1007/s00464-021-08395-0
pubmed: 35790593
pmcid: 9283340
Kim, B. H. et al. Standardized pathology report for colorectal cancer, 2nd eition. J. Pathol. Transl. Med. 54, 1 (2020).
doi: 10.4132/jptm.2019.09.28
pubmed: 31722452
Rollvén, E. et al. Morphological predictors for lymph node metastases on computed tomography in colon cancer. Abdom. Radiol. 44, 1712–1721 (2019).
doi: 10.1007/s00261-019-01900-z
Brown, G. Staging rectal cancer: Endoscopic ultrasound and pelvic MRI. Cancer Imaging 8, S43 (2008).
doi: 10.1102/1470-7330.2008.9008
pubmed: 18852080
pmcid: 2582501
Henderson, A. R. Testing experimental data for univariate normality. Clin. Chim. Acta 366, 112–129 (2006).
doi: 10.1016/j.cca.2005.11.007
pubmed: 16388793
Søreide, K., Kørner, H. & Søreide, J. A. Diagnostic accuracy and receiver-operating characteristics curve analysis in surgical research and decision making. Ann. Surg. 253, 27–34 (2011).
doi: 10.1097/SLA.0b013e318204a892
pubmed: 21294285
Mandrekar, J. N. Receiver operating characteristic curve in diagnostic test assessment. J. Thorac. Oncol. 5, 1315–1316 (2010).
doi: 10.1097/JTO.0b013e3181ec173d
pubmed: 20736804
Cheong, C. K. et al. Neoadjuvant therapy in locally advanced colon cancer: A meta-analysis and systematic review. J. Gastrointest. Oncol. 11, 847–857 (2020).
doi: 10.21037/jgo-20-220
pubmed: 33209481
pmcid: 7657836
Nerad, E. et al. Diagnostic accuracy of CT for local staging of colon cancer: A systematic review and meta-analysis. Am. J. Roentgenol. 207, 984–995 (2016).
doi: 10.2214/AJR.15.15785
Hennedige, T., Teo, L., Ang, B., Cheong, W. K. & Venkatesh, S. K. Accuracy of preoperative CT for local staging in colorectal carcinomas. Singap. Med. J. 51, 475–480 (2010).
Panarelli, N. C. et al. Reproducibility of AJCC criteria for classifying deeply invasive colon cancers is suboptimal for consistent cancer staging. Am. J. Surg. Pathol. 44, 1381–1388 (2020).
doi: 10.1097/PAS.0000000000001510
pubmed: 32931163
Mc Entee, P. D. et al. Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death. Eur. J. Surg. Oncol. 48, 1638–1642 (2022).
doi: 10.1016/j.ejso.2022.02.013
pubmed: 35249791
Kim, T. H., Woo, S., Han, S., Suh, C. H. & Vargas, H. A. The diagnostic performance of MRI for detection of extramural venous invasion in colorectal cancer: A systematic review and meta-analysis of the literature. Am. J. Roentgenol. 213, 575–585 (2019).
doi: 10.2214/AJR.19.21112